Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC for MACE in STEMI patients undergoing PCI
NCT01878344Phase 3Active, not recruiting
- Sponsor
- Suleyman Demirel University
- Start
- Jan 2013
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of acetylcysteine in ST elevation myocardial infarction (STEMI) (2 arms), sponsored by Suleyman Demirel University. Primary endpoint: Major cardiac and cerebral events at 1 year. Started Jan 2013; status: active, not recruiting.
02
Drugs
acetylcysteine
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT01878344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01878344.